[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Page 10080]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02881]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--SIP24-006, Nutrition Obesity
Policy Research and Evaluation Network (NOPREN); SIP24-007, Physical
Activity Policy and Evaluation Research Network (PAPREN): Policy
Implementation Research to Advance Health Equity; and SIP24-010, Mental
Health and Chronic Disease Prevention Network.
Date: May 2, 2024.
Time: 10 a.m.-6 p.m., EDT.
Place: Teleconference/Web Conference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Catherine Barrett, Ph.D.,
Scientific Review Officer, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Highway, Mailstop S106-3, Atlanta, Georgia
30341-3717. Telephone: (404) 718-7664; Email: [email protected].
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02881 Filed 2-12-24; 8:45 am]
BILLING CODE 4163-18-P